Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01190384 · ClinicalTrials.gov registry record · NA

The Effect of Whole Beans on Inflammation and Satiety

A NA study of Metabolic Syndrome, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT01190384: Completed NA study of Metabolic Syndrome, sponsored by University of California, Davis.

NCT01190384 is a NA study of Metabolic Syndrome that has completed, run by University of California, Davis. The registered enrollment target is 12 participants, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01190384, a NA study of Metabolic Syndrome, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

Determine whether eating beans with a high fat meal will reduce the inflammatory response in people with the metabolic syndrome and increase feelings of satiety.

Primary Outcome

Measuring inflammatory markers after consumption of a high fat meal in conjunction with one of three soups. The three soups are: a bean soup high in fiber and antioxidants, a couscous soup high in fiber, and a couscous soup high in antioxidants.

Conditions Studied

Interventions

  • OTHER Couscous plus fiber
  • DIETARY_SUPPLEMENT Grape seed extract
  • OTHER Bean Soup

Study Locations (1)

California

  • Ragle Human Nutrition Research Center - Davis

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2010-08
Est. Completion 2014-04
Phase NA
University of California, Davis

657 total trials

What the finished NCT01190384 record still lists

NCT01190384 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Metabolic Syndrome appearing as the primary indexed condition, and to 3 interventions - of which Couscous plus fiber is the first listed.

NCT01190384 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01190384 about?

NCT01190384 is a clinical study titled "The Effect of Whole Beans on Inflammation and Satiety". Determine whether eating beans with a high fat meal will reduce the inflammatory response in people with the metabolic syndrome and increase feelings of satiety.

What is the current status of trial NCT01190384?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2010-08. Estimated completion is 2014-04.

What conditions does trial NCT01190384 study?

This clinical trial studies the following conditions: Metabolic Syndrome.

What interventions are being tested in trial NCT01190384?

The interventions under investigation include: Couscous plus fiber (OTHER), Grape seed extract (DIETARY_SUPPLEMENT), Bean Soup (OTHER).

Who is sponsoring clinical trial NCT01190384?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01190384 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01190384's enrollment target sits among peer trials

12 100th of 102 higher than 3 of 102 other Metabolic Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Metabolic Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01190384, the US trial registry maintained by the National Library of Medicine. NCT01190384 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.